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Background
The left ventricular (LV) papillary muscles (PM) are
important structure for mitral valve complex. Previous
studies by echocardiography demonstrated that PM func-
tion was impaired in patients with hypertrophic cardio-
myopathy (HCM) and dilated cardiomyopathy (DCM).
Native T1 mapping has emerged as a noninvasive mag-
netic resonance (MR) imaging method to assess LV diffuse
myocardial fibrosis without using contrast agent. The aims
of this study were to evaluate feasibility and reproducibility
of PM native T1 measurement, and to compare PM T1
times between cardiomyopathy patients and controls
subjects.
Methods
Seventeen cardiomyopathy patients (11 HCM; 6 DCM,
age: 57 ± 15 years) and 16 control subjects (age: 50 ± 15
years) were enrolled. Native T1 mapping images were
acquired with MOLLI (Messroghli DR et al. MRM 2004)
sequence in 3 short-axis planes (basal, mid and apical
slices) using an ECG-triggered single-shot acquisition with
a balanced SSFP readout (TR, 3.1; TE, 1.5; FA, 35°; FOV,
360 × 337 mm2; acquisition matrix, 188 × 135; voxel size,
1.9 × 2.5 mm2; slice thickness, 8 mm). All data were cor-
rected for motion (Roujol S et al. MRM 2014). Measure-
ment of PM T1 was performed both in anterior PM and
posterior PM in all subjects. Intra-observer and inter-
observer reproducibility was assessed by 2 readers in 20
PMs from 10 control subjects. Repeatability coefficients
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Figure 1 Comparison of papillary muscle T1 between cardiomyopathy patients and control subjects. Significant difference was found in
native T1 value both in anterior papillary muscle and posterior papillary muscle between control subjects and cardiomyopathy patients.
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were calculated as 1.96 times the standard deviation of the
differences on the Bland-Altman plots.
Results
Intra- and inter- observer reproducibility of PM native T1
measurement was high. Repeatability coefficient of 10.2
msec, intraclass correlation coefficient (ICC) of 0.99 (95%
confidence interval (CI): 0.99 -1.00, p<0.05) and coefficient
of variation (CV) of 0.36% for intra-observer reproducibil-
ity. Repeatability coefficient of 15.4 msec, ICC of 0.99
(95% CI: 0.99 -1.00, p<0.05), CV of 0.63% for inter-obser-
ver reproducibility. Comparing cardiomyopathy patients
and control subjects, significant difference was found both
in anterior PM T1 value (1102 ± 43 msec vs 1102 ± 90
msec, p=0.003) and posterior PM T1 value (1100 ± 69
msec vs 1010 ± 69 msec, p=0.002).
Conclusions
Measurement of PM native T1 is feasible and reproducible.
This MR approach successfully detected abnormal PM T1
value in cardiomyopathy patients, and could provide new
insight into possible pathophysiological mechanism of PM
dysfunction in various cardiovascular diseases.
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